{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:24:46Z","timestamp":1792095886811,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170592"],"award-info":[{"award-number":["82170592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871947"],"award-info":[{"award-number":["81871947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200684"],"award-info":[{"award-number":["82200684"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072652"],"award-info":[{"award-number":["82072652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970545"],"award-info":[{"award-number":["81970545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170609"],"award-info":[{"award-number":["82170609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221032"],"award-info":[{"award-number":["BK20221032"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jhepr.2023.100805","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T21:28:16Z","timestamp":1685136496000},"page":"100805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["C\u2013C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Zhiwen","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulian","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100805_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease \u2013 meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100805_bib2","article-title":"Genetic predisposition similarities between NASH and ASH: identification of new therapeutic targets","volume":"3","author":"Bianco","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib3","article-title":"Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"3","author":"Younossi","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib4","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100805_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100805_bib6","article-title":"Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD \u2013 reconciling the present with the past","volume":"3","author":"Ayonrinde","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib7","article-title":"Evaluating causality of cellular senescence in non-alcoholic fatty liver disease","volume":"3","author":"Meijnikman","year":"2021","journal-title":"JHEP Rep"},{"issue":"Suppl 1","key":"10.1016\/j.jhepr.2023.100805_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"Bedossa","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100805_bib9","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100805_bib10","article-title":"Defatting strategies in the current era of liver steatosis","volume":"3","author":"Mazilescu","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib11","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib12","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2468-1253(17)30365-5","article-title":"The painful reality of end-stage liver disease in NASH","volume":"3","author":"Ratziu","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100805_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100805_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology \u2013 divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhepr.2023.100805_bib16","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1074\/jbc.M111421200","article-title":"Diminished hepatic response to fasting\/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c","volume":"277","author":"Liang","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100805_bib17","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI119746","article-title":"Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene","volume":"100","author":"Shimano","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100805_bib18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1172\/JCI119247","article-title":"Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells","volume":"99","author":"Shimomura","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100805_bib19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI119248","article-title":"Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells","volume":"99","author":"Shimano","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100805_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100805_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100805_bib22","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/medicina58060761","article-title":"An update on the chemokine system in the development of NAFLD","volume":"58","author":"Nagata","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jhepr.2023.100805_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100805_bib25","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2023.100805_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20110515","article-title":"Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis","volume":"123","author":"Galastri","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhepr.2023.100805_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154914","article-title":"CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1\/M2 status in mice","volume":"125","author":"Xu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2023.100805_bib28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.179.3.881","article-title":"Eotaxin: a potent eosinophil chemoattractant cytokine detected in a Guinea pig model of allergic airways inflammation","volume":"179","author":"Jose","year":"1994","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2023.100805_bib29","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1440-1746.2006.04621.x","article-title":"Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course","volume":"22","author":"Tacke","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100805_bib30","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1371\/journal.pntd.0000598","article-title":"Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis","volume":"4","author":"Burke","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jhepr.2023.100805_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)00057-X","article-title":"Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease","volume":"34","author":"Pham","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100805_bib32","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.4049\/jimmunol.171.6.3233","article-title":"Crucial role of IL-4\/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes","volume":"171","author":"Jaruga","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2023.100805_bib33","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1038\/sj.emboj.7600468","article-title":"Crosstalk between PKCzeta and the IL4\/Stat6 pathway during T-cell-mediated hepatitis","volume":"23","author":"Duran","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.jhepr.2023.100805_bib34","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/hep.26196","article-title":"Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice","volume":"57","author":"Proctor","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100805_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/jc.2005-1280","article-title":"Eotaxin and obesity","volume":"91","author":"Vasudevan","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100805_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/cen.12113","article-title":"Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial","volume":"79","author":"Loughrey","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 2","key":"10.1016\/j.jhepr.2023.100805_bib37","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/diabetes.54.suppl_2.S11","article-title":"Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)","volume":"54","author":"Herder","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2023.100805_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/00365513.2021.1876245","article-title":"Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection","volume":"81","author":"Wong","year":"2021","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jhepr.2023.100805_bib39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0002-9440(10)61235-7","article-title":"Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis","volume":"167","author":"Huaux","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2023.100805_bib40","first-page":"3925","article-title":"Selective glucocorticoid receptor modulation prevents and reverses nonalcoholic fatty liver disease in male mice","volume":"159","author":"Koorneef","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2023.100805_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118765","article-title":"Dexamethasone programs lower fatty acid absorption and reduced PPAR-gamma and fat\/CD36 expression in the jejunum of the adult rat offspring","volume":"265","author":"de Souza","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.jhepr.2023.100805_bib42","article-title":"The chromatin remodeling protein BRG1 regulates SREBP maturation by activating SCAP transcription in hepatocytes","volume":"9","author":"Kong","year":"2021","journal-title":"Front Cel Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41419-022-04944-0","article-title":"Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration","volume":"13","author":"Fan","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2023.100805_bib44","article-title":"Dual regulation of tank binding kinase 1 (TBK1) by BRG1 in hepatocytes contributes to ROS production","volume":"9","author":"Lv","year":"2021","journal-title":"Front Cel Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102079","article-title":"Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury","volume":"46","author":"Kong","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib46","article-title":"Choline kinase alpha is a novel transcriptional target of the Brg1 in hepatocyte: implication in liver regeneration","volume":"9","author":"Kong","year":"2021","journal-title":"Front Cel Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib47","article-title":"An E2F5-TFDP1-BRG1 complex mediates transcriptional activation of MYCN in hepatocytes","volume":"9","author":"Fan","year":"2021","journal-title":"Front Cel Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib48","article-title":"BRG1 links TLR4 trans-activation to LPS-induced SREBP1a expression and liver injury","volume":"9","author":"Dong","year":"2021","journal-title":"Front Cel Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib49","article-title":"Epigenetic repression of chloride channel accessory 2 transcription in cardiac fibroblast: implication in cardiac fibrosis","volume":"9","author":"Shao","year":"2021","journal-title":"Front Cel Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib50","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib51","article-title":"Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases","volume":"3","author":"Sanyal","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib52","article-title":"PI3Kgamma promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation","volume":"3","author":"Becattini","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib53","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1002\/ctm2.688","article-title":"Myocardin-related transcription factor A drives ROS-fueled expansion of hepatic stellate cells by regulating p38-MAPK signalling","volume":"12","author":"Dong","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jhepr.2023.100805_bib54","article-title":"Down-regulation of CXXC5 de-represses MYCL1 to promote hepatic stellate cell activation","volume":"9","author":"Wu","year":"2021","journal-title":"Front Cel Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cmet.2017.08.003","article-title":"The FGF21-CCL11 axis mediates beiging of white adipose tissues by coupling sympathetic nervous system to type 2 immunity","volume":"26","author":"Huang","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2023.100805_bib56","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M116.714824","article-title":"Neutralization of RANTES and eotaxin prevents the loss of dopaminergic neurons in a mouse model of Parkinson disease","volume":"291","author":"Chandra","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100805_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100805_bib58","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100805_bib59","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100805_bib60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaci.2005.08.057","article-title":"The CC chemokine eotaxin\/CCL11 has a selective profibrogenic effect on human lung fibroblasts","volume":"117","author":"Puxeddu","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100805_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(05)80086-8","article-title":"Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development","volume":"75","author":"Matsuyama","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2023.100805_bib62","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/hep.23501","article-title":"Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury","volume":"51","author":"Ueki","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100805_bib63","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.4049\/jimmunol.1402505","article-title":"IRF-1 promotes liver transplant ischemia\/reperfusion injury via hepatocyte IL-15\/IL-15Ralpha production","volume":"194","author":"Yokota","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2023.100805_bib64","doi-asserted-by":"crossref","first-page":"18466","DOI":"10.1074\/jbc.RA118.005583","article-title":"Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: distinct roles of interferon regulatory factor-1 in liver injury","volume":"293","author":"Rani","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100805_bib65","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.4049\/jimmunol.1000092","article-title":"A\u00a0critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide","volume":"185","author":"Cao","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2023.100805_bib66","doi-asserted-by":"crossref","first-page":"a001222","DOI":"10.1101\/cshperspect.a001222","article-title":"p53-based cancer therapy","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jhepr.2023.100805_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \u201cundruggable\u201d MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhepr.2023.100805_bib68","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2007-2630","article-title":"CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity","volume":"93","author":"Huber","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2023.100805_bib69","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3803\/EnM.2020.942","article-title":"Effect of CCL11 on in\u00a0vitro myogenesis and its clinical relevance for sarcopenia in older adults","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.jhepr.2023.100805_bib70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exger.2011.10.005","article-title":"Inflammation-related muscle weakness and fatigue in geriatric patients","volume":"47","author":"Beyer","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jhepr.2023.100805_bib71","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12072-020-10066-6","article-title":"Cell cycle regulation in NAFLD: when imbalanced metabolism limits cell division","volume":"14","author":"Caldez","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100805_bib72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jhepr.2023.100805_bib73","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1038\/s41598-018-25699-9","article-title":"Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100805_bib74","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2016.08.006","article-title":"Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress","volume":"180","author":"Li","year":"2017","journal-title":"Transl Res"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:06:37Z","timestamp":1778904397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":74,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2589555923001362"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100805","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\u2013C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100805"}}